Targeting Tyrosine Kinase and Mammalian Target of Rapamycin inhibitors in the Treatment of Breast Cancer.
Mona Kamal Jomaa;
Abstract
Breast cancer alone is expected to account for 27% of all new cancer cases among women
Our understanding of the biology of breast cancer is increasing steadily this allow field of personalized medicine to expand and this lead to more effective treatment
Our understanding of the biology of breast cancer is increasing steadily this allow field of personalized medicine to expand and this lead to more effective treatment
Other data
| Title | Targeting Tyrosine Kinase and Mammalian Target of Rapamycin inhibitors in the Treatment of Breast Cancer. | Other Titles | استهداف مثبطات التيروزين كينازوالراباميسين فى علاج سرطان الثدى | Authors | Mona Kamal Jomaa | Keywords | Targeting Tyrosine Kinase and Mammalian Target of Rapamycin inhibitors in the Treatment of Breast Cancer. | Issue Date | 2009 | Description | Breast cancer alone is expected to account for 27% of all new cancer cases among women Our understanding of the biology of breast cancer is increasing steadily this allow field of personalized medicine to expand and this lead to more effective treatment |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 95595p532.pdf | 449.59 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.